Contract #HHSN272201800011I IDT biologika development and manufacture of toxoid fusion 3XSTAN12SMNLTR192GL211A and CF, i, II, IV master banks can 8470038 total $555,600.00
Ended Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,209,261
Award facts
- Contract value 71% obligated
-
- $1,209,261.00 Current, with exercised options
- $1,693,261.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $65,800 | |
| Funding Only Action | $587,861 | |
| Other Administrative Action | $0 | |
| Original award | $555,600 |
About this award
This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $555,600.00 contract was awarded to IDT Biologika GMBH, a German biotechnology company, for the development and manufacture of toxoid fusion proteins and master cell banks. The contract has a total ceiling value of $1,693,261.00 and is a delivery order with a cost-plus-fixed-fee pricing structure. The contract does not have a set-aside designation. The services being provided under this contract are in support of infectious disease research and pandemic preparedness efforts.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 17, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $1,209,261 on 75N93020F00003. Its potential value, with all options, is $1,693,261.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award